The story starts with a fruit drink, at least in its maker's telling. In the early 1920s the French microbiologist Henri Boulard, posted to French Indochina, saw locals drink a preparation of lychees and mangosteens for the digestive troubles of cholera, and in 1923 he isolated the yeast that now carries his name. The French firm Biocodex bought the rights in 1953 and registered its strain at the Institut Pasteur as CNCM I-745 in 1988. It is sold in France as the medicine Ultra-Levure, for diarrhoea alongside rehydration, and in North America since 2002 as the supplement Florastor.
It is the odd one out among probiotics, a yeast rather than a bacterium. Taxonomists now treat it as a form of baker's yeast, and NCBI files S. boulardii as a name not validly published, under S. cerevisiae, which is why the atlas gives it as S. cerevisiae var. boulardii. Its evidence is the strongest of any microbe in the atlas for one job, preventing antibiotic diarrhoea in children. Its main hazard is just as specific: rare bloodstream infections in very sick or immunocompromised patients, which is why France now rules it out for them.
At home
Not a home remedy. It's a freeze-dried medicine-grade yeast sold in capsules and sachets, with no home version. Don't open capsules near anyone who is very ill or has a central line.
My tummy is… the evidence in full
S. boulardii (mostly CNCM I-745) capsules or sachets taken with antibiotics, to prevent diarrhoea
Paediatric gastroenterologists in Europe (ESPGHAN), reviewing strain-specified trials with GRADE, rated the evidence that S. boulardii prevents antibiotic-associated diarrhoea in children as moderate quality and recommended it. A 2015 meta-analysis found it cut the risk in children from about 21% to 9%. For C. difficile diarrhoea specifically, the evidence in children is low quality.
Sources: Journal of Pediatric Gastroenterology and… 2016clinical guidelineAlimentary Pharmacology & Therapeutics 2015systematic reviewCochrane Database of Systematic Reviews 2019Cochrane review
S. boulardii capsules or sachets taken with antibiotics, to prevent diarrhoea
A 2015 meta-analysis of 15 trials in 3114 adults found S. boulardii cut antibiotic-associated diarrhoea from about 17% to 8%, though not C. difficile diarrhoea. The review used GRADE, but its abstract doesn't give the certainty for adults, and a 2025 Cochrane review rated the evidence for probiotics as a group, in adults and children, as low certainty for this outcome.
Sources: Alimentary Pharmacology & Therapeutics 2015systematic reviewCochrane Database of Systematic Reviews 2025Cochrane review
LooseSome evidencevery low certainty · children with acute gastroenteritis S. boulardii given during acute gastroenteritis, alongside rehydration
A 2020 meta-analysis of 29 trials found children given S. boulardii had diarrhoea for about a day less and left hospital a little sooner, but most trials were poorly concealed and unblinded, and the reviewers rated the evidence low to very low quality.
Sources: Alimentary Pharmacology & Therapeutics 2020systematic review
S. boulardii CNCM I-745 alone
A 2026 strain-by-strain meta-analysis of probiotics for IBS found conflicting results for this strain.
Sources: Journal of Clinical Medicine 2026systematic review
How we grade the evidence
Found in
- Florastor capsule · France and Iberia
● Confirmed
The regulator's view
- The EMA has never assessed this plant.
Relatives in the atlas
More from the yeast family.
Kluyveromyces marxianus
One of the two defining cultures of kumis and the… · in 2 preparations
Ferment